Long GV, Nair N, Marbach D, Scolyer RA, et al. Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial. Nat Med 2025 Sep 24. doi: 10.1038/s41591-025-03967.
PMID: 40993242